Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2025-12-26 @ 1:42 AM
Study NCT ID:
NCT00240994
Status:
COMPLETED
Last Update Posted:
2017-01-02
First Post:
2005-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-14
First Submit QC Date:
None
Study First Post Date:
2005-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-09-13
Results First Submit QC Date:
None
Results First Post Date:
2012-10-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-15
Last Update Post Date:
2017-01-02
Last Update Post Date Type:
ESTIMATED